Matches in Nanopublications for { ?s ?p "[We evaluated BCR-ABL expression in CD34(+)CD38(+) (38(+)) committed progenitors and CD34(+)CD38(-) (38(-)) stem/primitive progenitor cells in samples from CML patients on imatinib treatment for at least 4 years with cytogenetic and molecular response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_assertion description "[We evaluated BCR-ABL expression in CD34(+)CD38(+) (38(+)) committed progenitors and CD34(+)CD38(-) (38(-)) stem/primitive progenitor cells in samples from CML patients on imatinib treatment for at least 4 years with cytogenetic and molecular response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_provenance.
- assertion description "[We evaluated BCR-ABL expression in CD34(+)CD38(+) (38(+)) committed progenitors and CD34(+)CD38(-) (38(-)) stem/primitive progenitor cells in samples from CML patients on imatinib treatment for at least 4 years with cytogenetic and molecular response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We evaluated BCR-ABL expression in CD34(+)CD38(+) (38(+)) committed progenitors and CD34(+)CD38(-) (38(-)) stem/primitive progenitor cells in samples from CML patients on imatinib treatment for at least 4 years with cytogenetic and molecular response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_assertion description "[We evaluated BCR-ABL expression in CD34(+)CD38(+) (38(+)) committed progenitors and CD34(+)CD38(-) (38(-)) stem/primitive progenitor cells in samples from CML patients on imatinib treatment for at least 4 years with cytogenetic and molecular response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294108.RAXpRVUUykH1D-MltUuPIynChATeM3W0mxoUJf7XbvSs4130_provenance.
- NP924857.RAb8istoyAjXGaclTXfhCHR0Pp7o9zIU0KnIun3remi2w130_assertion description "[We evaluated BCR-ABL expression in CD34(+)CD38(+) (38(+)) committed progenitors and CD34(+)CD38(-) (38(-)) stem/primitive progenitor cells in samples from CML patients on imatinib treatment for at least 4 years with cytogenetic and molecular response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924857.RAb8istoyAjXGaclTXfhCHR0Pp7o9zIU0KnIun3remi2w130_provenance.
- NP924856.RAhn4wmoqIoJcuTHHaUpQCO7HeHQ7I9kaSWdW4HycqxXo130_assertion description "[We evaluated BCR-ABL expression in CD34(+)CD38(+) (38(+)) committed progenitors and CD34(+)CD38(-) (38(-)) stem/primitive progenitor cells in samples from CML patients on imatinib treatment for at least 4 years with cytogenetic and molecular response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924856.RAhn4wmoqIoJcuTHHaUpQCO7HeHQ7I9kaSWdW4HycqxXo130_provenance.